If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    -3.00 (-0.51%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £237.41m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Proposed Director Dealing

30 Sep 2020 13:30

RNS Number : 6272A
Science Group PLC
30 September 2020
 

 

 

 

30 September 2020

 

Science Group plc

(the "Company" or "Science Group")

 

 

Proposed Director Dealing

 

Science Group announces that it has been notified by Martyn Ratcliffe, Executive Chairman of the Company of his intention to sell up to 2,000,826 ordinary shares of £0.01 each in the Company ("Sale Shares") at a price of 240 pence per Sale Share (the "Sale").

The Sale Shares represent approximately 4.8% of the Company's issued share capital excluding treasury shares. Assuming all the Sale Shares are sold, Martyn Ratcliffe will, following completion of the Sale, continue to have an interest in approximately 27.25% of the issued share capital (excluding treasury shares) of the Company.

Martyn Ratcliffe has undertaken that he will not dispose of any further ordinary shares for a period of 12 months after completion of the Sale (subject to customary exceptions).

The Company is not a party to the Sale and will not receive any proceeds from the Sale.

Background to the Transaction

In January 2019, at the conclusion of the strategic review, the Board of Science Group highlighted that while "the Company benefits from a supportive shareholder base, the lack of liquidity creates a market inefficiency which may impact the valuation of the Group."

Since 2010, the largest shareholder in the Company has been the Executive Chairman, Martyn Ratcliffe, following his investment in March of that year and the subsequent placing in May 2010. Mr Ratcliffe's current shareholding is 13,412,906 shares equivalent to 32.03% of the issued share capital excluding treasury shares. Due to the scale of Mr Ratcliffe's shareholding, each year shareholders and the Takeover Panel must also approve a waiver of Rule 9 of the Takeover Code in order that the Company can undertake share buy-backs.

Mr Ratcliffe has now agreed to reduce his shareholding in order to broaden the shareholder base and reduce shareholder concentration through the Sale. Following this transaction, Mr Ratcliffe will remain the Group's largest shareholder.

 

End

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

www.sciencegroup.com

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

MHP Communications (PR Advisor to Science Group)

Reg Hoare, James Bavister, Pete Lambie

Tel: +44 (0) 20 3128 8100

sciencegroup@mhpc.com

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (No 596/2014). The person responsible for this announcement is Sarah Cole, Company Secretary.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKKBDBBKDCCN
Date   Source Headline
24th Jul 20237:00 amRNSInterim results for 6 months ended 30 June 2023
18th Jul 20231:35 pmRNSNotice of Interim Results
13th Jul 20237:00 amRNSHolding(s) in Company
12th Jun 20234:33 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSTransaction in Own Shares
18th May 202311:50 amRNSResult of AGM
18th May 20237:00 amRNSAGM Trading and Board Update
15th May 20237:00 amRNSIssue of share options & PDMR dealing
12th May 20232:05 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Share & Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSPosting of documents and Notice of AGM
12th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
16th Mar 20231:00 pmRNSNotice of Preliminary Results
14th Mar 20234:45 pmRNSHolding(s) in Company
14th Mar 20233:00 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement re banking arrangements
13th Mar 20237:00 amRNSBanking Arrangements
2nd Mar 20233:06 pmRNSHolding(s) in Company
10th Feb 20231:20 pmRNSHolding(s) in Company
9th Feb 20232:45 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSCompletion of Sale of Westek Technology Ltd
31st Jan 202312:25 pmRNSHolding(s) in Company
31st Jan 202311:35 amRNSHolding(s) in Company
26th Jan 202310:05 amRNSScheme Effective
24th Jan 20232:21 pmRNSCourt Sanction of Scheme of Arrangement
9th Jan 20237:00 amRNSRegulatory Clearance & Scheme Timetable Update
15th Dec 20227:00 amRNSPre-Close Trading and Business Update
14th Dec 20223:33 pmRNSResult of Court Meeting & General Meeting
30th Nov 20224:35 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSExercise of Share Options
24th Nov 20221:13 pmRNSHolding(s) in Company
21st Nov 20227:00 amRNSPublication of Scheme Document
10th Nov 20227:00 amRNSForm 8 (OPD) (TP Group plc)
7th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.